Adenocarcinoma of the Pancreas Completed Phase 3 Trials for Bevacizumab (DB00112)

Also known as: Pancreatic adenocarcinoma / Adenocarcinoma Pancreas / Pancreas, Adenocarcinoma / Pancreas Adenocarcinoma / Adenocarcinoma of Pancreas / Adenocarcinoma, Pancreas

IndicationStatusPhase
DBCOND0029532 (Adenocarcinoma of the Pancreas)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00088894Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerTreatment